Your browser is no longer supported. Please, upgrade your browser.
Settings
ILMN Illumina Inc. daily Stock Chart
ILMN [NASD]
Illumina Inc.
IndexS&P 500 P/E43.90 EPS (ttm)3.10 Insider Own1.20% Shs Outstand147.91M Perf Week-5.00%
Market Cap20.10B Forward P/E32.63 EPS next Y4.17 Insider Trans-11.03% Shs Float145.60M Perf Month-18.54%
Income461.60M PEG2.62 EPS next Q0.74 Inst Own93.10% Short Float4.10% Perf Quarter-14.48%
Sales2.22B P/S9.06 EPS this Y30.50% Inst Trans0.61% Short Ratio3.89 Perf Half Y-6.73%
Book/sh12.66 P/B10.74 EPS next Y19.34% ROA12.60% Target Price171.05 Perf Year-28.92%
Cash/sh9.37 P/C14.50 EPS next 5Y16.74% ROE25.60% 52W Range130.00 - 242.37 Perf YTD-29.19%
Dividend- P/FCF38.93 EPS past 5Y28.90% ROI16.60% 52W High-45.13% Beta0.84
Dividend %- Quick Ratio3.00 Sales past 5Y19.70% Gross Margin69.80% 52W Low2.30% ATR6.31
Employees4600 Current Ratio3.40 Sales Q/Q15.40% Oper. Margin27.60% RSI (14)33.25 Volatility2.74% 3.22%
OptionableYes Debt/Eq0.59 EPS Q/Q-32.00% Profit Margin20.80% Rel Volume2.49 Prev Close135.92
ShortableYes LT Debt/Eq0.55 EarningsMay 03 AMC Payout0.00% Avg Volume1.54M Price132.99
Recom2.40 SMA20-14.39% SMA50-14.31% SMA200-22.91% Volume508,866 Change-2.16%
Apr-19-16Downgrade Cantor Fitzgerald Buy → Hold
Apr-19-16Downgrade BofA/Merrill Buy → Neutral
Feb-04-16Downgrade Canaccord Genuity Buy → Hold $205 → $160
Feb-03-16Reiterated Deutsche Bank Hold $178 → $160
Jan-07-16Reiterated Barclays Equal Weight $170 → $175
Jan-07-16Initiated Deutsche Bank Hold $192
Jan-07-16Downgrade Wells Fargo Outperform → Market Perform
Dec-21-15Reiterated Stifel Buy $175 → $215
Oct-13-15Reiterated Barclays Equal Weight $215 → $170
Oct-06-15Reiterated Stifel Buy $235 → $175
Oct-06-15Reiterated Piper Jaffray Overweight $230 → $220
Oct-06-15Reiterated Leerink Partners Mkt Perform $185 → $155
Oct-06-15Reiterated Goldman Neutral $230 → $137
Oct-06-15Downgrade Mizuho Buy → Neutral $250 → $150
Oct-01-15Downgrade Leerink Partners Outperform → Mkt Perform
Aug-27-15Initiated Cantor Fitzgerald Buy
Aug-19-15Reiterated Mizuho Buy $240 → $250
Jul-22-15Reiterated Mizuho Buy $230 → $240
Jul-22-15Reiterated Canaccord Genuity Buy $275 → $250
May-21-15Upgrade Morgan Stanley Equal-Weight → Overweight $162 → $190
May-03-16 07:07AM  Q1 2016 Illumina Inc Earnings Release - After Market Close CCBN
Apr-30-16 12:01AM  [$$] A Healthy Prognosis for Drugs and Robots at Barrons.com
Apr-28-16 12:06PM  Why Illumina Cratered by 24% Last Week at Motley Fool
Apr-27-16 06:30AM  Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care Conference Business Wire
Apr-26-16 09:05PM  Large-Cap Update: Illuminas Stock Tanks on New Earnings Estimate Market Realist
08:24AM  Does Illumina Inc.'s Slowing Growth Mean It's Time to Sell? at Motley Fool
06:25AM  One Year Later: Whatever Happened To Those Biotech Companies? at Forbes
Apr-25-16 08:20AM  Is Pacific Biosciences or Illumina Corp. a Better Buy? at Motley Fool
Apr-23-16 02:02PM  How the Scientific Method Can Make You a Better Investor at Motley Fool
12:01AM  [$$] Charting the Market at Barrons.com
Apr-21-16 05:26PM  ETFs with exposure to Illumina, Inc. : April 21, 2016 at Capital Cube
04:05PM  Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents Business Wire
Apr-20-16 12:35PM  Facebook Passed 50-Day Test; Netflix, Illumina Broke 2 Support Areas at Investor's Business Daily
09:39AM  Illumina (ILMN) Shareholder Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Illumina, Inc. PR Newswire
08:21AM  Illumina's Gene Sequencers Are About to Revolutionize Healthcare at Motley Fool
08:15AM  Illumina, Inc. breached its 50 day moving average in a Bearish Manner : ILMN-US : April 20, 2016 at Capital Cube
01:31AM  [$$] Illumina Shares Take Hit on Weakness in Europe at The Wall Street Journal
Apr-19-16 07:38PM  Netflix Inc. and Illumina Inc. Dive As Indexes Rise at Motley Fool -23.16%
07:00PM  Facebook Passes 50-Day Test; Netflix, Illumina Break 2 Support Lines
06:21PM  Are Illumina's Shares Worth Buying on This Drop? at Motley Fool
05:31PM  Heres Why This Genetics Biotechs Stock Plunged Today at Fortune
04:22PM  Illumina shares tumble after revised revenue estimate
03:35PM  [$$] Illumina Selloff Offers a Good Buying Opportunity at Barrons.com
01:31PM  Here's Why Illumina (ILMN) Stock Is Tanking Today at TheStreet
12:17PM  4 Stocks, 4 trades: ILMN, UNH, HOG & FCX
11:41AM  Stocks Mixed, But Growth Stocks Lag; New High For New Oriental
11:31AM  Wall Street is Dead Wrong: Why It's Time to Buy Illumina
10:47AM  Illumina shares tank after big revenue miss at CNBC
10:40AM  Why These 5 Stocks Are Making Noise Today at Insider Monkey
09:47AM  Stocks Mixed In Early Trade; Harley Reverses, Netflix Tumbles
09:15AM  Top Analyst Upgrades and Downgrades: Devon Energy, Illumina, Pandora, Panera, Potash, Regions Financial, Southwestern Energy and More at 24/7 Wall St.
08:35AM  Why Illumina Shares Are Tanking 18% Pre-Market at Motley Fool
08:04AM  Early movers: UNH, JNJ, GS, HOG, PM, EBAY & more at CNBC
07:54AM  Illumina Falls 20% After Preliminary Q1 Results 'Fell Short Of Expectations'
12:56AM  Edited Transcript of ILMN earnings conference call or presentation 18-Apr-16 8:30pm GMT
Apr-18-16 06:59PM  [$$] Illumina Lowers Revenue Guidance at The Wall Street Journal
05:40PM  Netflix, Illumina, IBM, Rambus Lead After-Hours Movers
05:19PM  Illumina Q1 Sales Miss Estimates; Stock Slammed
04:38PM  Illumina Drops Most Since 2011 as First-Quarter Sales Fall Short at Bloomberg
04:30PM  Preliminary Q1 2016 Illumina Inc Earnings Call scheduled for 4:30 pm ET today
04:20PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Illumina Announces Preliminary Revenue for First Quarter of Fiscal Year 2016 Business Wire
08:30AM  Is a Surprise Coming for Illumina (ILMN) This Earnings Season?
08:28AM  [$$] Illumina to Invest $100M Through Venture Fund at The Wall Street Journal
05:18AM  Illumina (ILMN): Stock Poised to Beat Q1 Earnings
Apr-16-16 12:03PM  Healthcare's Future: Science Fiction or Science Fact at Motley Fool
Apr-15-16 08:46AM  Illumina Announces $100 Million Investment In Venture Fund To 'Improve Human Health By Unlocking The Power Of The Genome'
Apr-14-16 04:18PM  Illumina Invests In New Venture Fund Business Wire
Apr-13-16 12:02PM  Illumina's "Moonshot" Startups May Be The Biggest Reason To Buy Its Shares at Motley Fool
Apr-08-16 01:55PM  Illumina Unveils BaseSpace Suite, Boosts Precision Medicine
01:42PM  How Did the Markets React to the Feds March Meeting Minutes?
Apr-07-16 02:05PM  Inside Thermo Fishers Affymetrix Acquisition: A Growth Gauge
Apr-06-16 11:25AM  Stocks Positive; Nasdaq At 200-Day; Halliburton, Baker-Hughes Surge +6.37%
09:20AM  [$$] Human Longevity Closes $220M Series B Financing at The Wall Street Journal
Apr-05-16 04:05PM  BioMed Realty Announces Illumina, Inc., As Sole Tenant For San Diego i3 Campus PR Newswire
06:30AM  Illumina Introduces BaseSpace┬« Informatics Suite to Accelerate Genomic Data Analysis for Sequence Labs Business Wire
Apr-01-16 01:03AM  [$$] Whole-genome breakthrough promises tonic for healthcare at Financial Times
Mar-30-16 10:10AM  Stock Market News for March 30, 2016
08:47AM  Apple Upgraded; Tesla Rating Backed Ahead Of Model 3
Mar-23-16 09:45AM  Biotech Roars Back On Forbes' List Of The Top Venture Capitalists at Forbes
08:13AM  Illumina, Inc. breached its 50 day moving average in a Bullish Manner : ILMN-US : March 23, 2016
Mar-20-16 08:43PM  Barron's Picks And Pans: FedEx, Ilumina And More
08:25PM  Barron's: The World's Best CEOs
Mar-19-16 12:01AM  [$$] Biotech Star Illumina's Bright Future Is in Its DNA at Barrons.com
Mar-18-16 05:41PM  Is This the Biggest Threat Yet to Illumina? at Motley Fool
Mar-16-16 12:28AM  Healthcare Sector: Industries Snapshot (XLV, JNJ) at Investopedia
Mar-14-16 11:39AM  Is It Time to Buy Illumina Inc. Stock? at Motley Fool
Mar-13-16 02:04PM  [$$] Cambridge Epigenetix secures $29m financing at Financial Times
Mar-12-16 10:21AM  Why Pacific Biosciences Lost 18.6% of Its Value Last Month at Motley Fool
Mar-09-16 01:04PM  ILLUMINA INC Financials
08:23AM  Illumina Stock Declines After Naming New CEO (ILMN) at Investopedia
08:10AM  Illumina, Inc. breached its 50 day moving average in a Bearish Manner : ILMN-US : March 9, 2016
Mar-08-16 02:41PM  Illumina (ILMN) Stock Drops on New CEO at TheStreet -6.92%
12:53PM  Instant Analysis: Illumina, Inc. Names New CEO at Motley Fool
12:07PM  Illumina Sells Off After Longtime CEO Announces Departure at Investor's Business Daily
06:05AM  ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-07-16 06:39PM  Illumina CEO Jay Flatley Built The DNA Sequencing Market. Now He's Stepping Down at Forbes
06:13PM  [$$] Illumina CEO Flatley To Step Down at The Wall Street Journal
04:33PM  How Will Illumina (ILMN) Stock React to New CEO? at TheStreet
04:05PM  Jay Flatley to Assume Role of Executive Chairman of the Board of Directors of Illumina; Francis deSouza Appointed President and CEO Business Wire
Mar-04-16 04:06PM  ILLUMINA INC Files SEC form 8-K, Other Events
Mar-02-16 04:14PM  ILLUMINA INC Files SEC form 10-K, Annual Report
Feb-24-16 06:30AM  Illumina Applies CE Mark to VeriSeq NIPT Analysis Software Business Wire
Feb-23-16 04:05PM  Illumina Sues Oxford Nanopore for Patent Infringement Business Wire
06:30AM  Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference Business Wire
Feb-11-16 04:12PM  Meet the Google executive tapped to run the cancer-screening startup backed by Bill Gates and Jeff Bezos
04:00AM  Genomics England Enters Bioinformatics Partnership with Illumina Business Wire
Feb-10-16 09:11AM  ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers
09:00AM  Google's Huber to Lead Illumina Cancer-Detecting Startup Grail at Bloomberg
09:00AM  Cancer Took His Wife. Now He's CEO Of One Of The Most Audacious Cancer Startups In Years at Forbes
06:30AM  Illumina Building Long Read Application Partnerships Business Wire
06:00AM  Former Google executive to lead cancer diagnostics firm Reuters
Feb-09-16 04:00PM  STZ carries Matrix Capital in January. WDAY & DATA drag
12:19PM  5 Things Illumina Inc.'s Management Wants You to Know at Motley Fool
Feb-08-16 03:00PM  Qiagen NV Is Prepping for Growth at Motley Fool
Feb-04-16 10:36AM  Illumina, Inc. Earnings Analysis: 2015 By the Numbers
09:43AM  Illumina downgraded by Canaccord Genuity
08:55AM  Top Analyst Upgrades and Downgrades: GoPro, Illumina, Mattel, Match, Peabody, Petrobras, Wayfair, Yahoo and More at 24/7 Wall St.
08:00AM  Analysts' Actions -- GoPro, Boston Beer, Match, Whirlpool and More
Feb-03-16 03:13PM  Illumina Inc. Reports Q4 Earnings Decline at Motley Fool
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company's sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 27Sale138.462,141296,44626,115Apr 28 06:34 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 18Sale176.012,141376,83528,256Apr 20 05:57 PM
Bianchi Paul LSr. VP, Human ResourcesApr 18Sale175.001,884329,70065,660Apr 20 05:33 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 13Option Exercise37.0412,500463,00042,897Apr 14 06:43 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 13Sale175.0012,5002,187,50030,397Apr 14 06:43 PM
WHITFIELD ROY ADirectorApr 12Option Exercise42.824,000171,2805,800Apr 14 06:21 PM
FLATLEY JAY TChief Executive OfficerApr 12Option Exercise36.3020,000726,000508,061Apr 14 06:42 PM
WHITFIELD ROY ADirectorApr 12Sale170.004,000680,0001,800Apr 14 06:21 PM
FLATLEY JAY TChief Executive OfficerApr 12Sale170.0520,0003,401,014488,061Apr 14 06:42 PM
WALT DAVID RDirectorApr 07Option Exercise13.304,00053,200635,840Apr 11 05:58 PM
WALT DAVID RDirectorApr 07Sale168.904,000675,596631,840Apr 11 05:58 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerApr 05Sale166.072,141355,54630,397Apr 06 05:29 PM
Dadswell CharlesSr VP & General CounselApr 04Sale167.818,3821,406,60449,859Apr 06 05:19 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMar 23Sale155.052,141331,95732,538Mar 23 05:41 PM
FLATLEY JAY TChief Executive OfficerMar 22Option Exercise36.3010,000363,000498,061Mar 23 05:39 PM
FLATLEY JAY TChief Executive OfficerMar 22Sale154.1810,0001,541,759488,061Mar 23 05:39 PM
BRADBURY DANIELDirectorMar 21Option Exercise44.511,20053,41215,576Mar 22 02:51 PM
Naclerio NicholasSr VP, Corporate DevelopmentMar 21Sale154.254,520697,21030,020Mar 22 02:48 PM
BRADBURY DANIELDirectorMar 21Sale155.631,200186,75614,376Mar 22 02:51 PM
BOWMAN A BLAINEDirectorMar 17Option Exercise36.295,000181,45018,615Mar 18 08:49 PM
BOWMAN A BLAINEDirectorMar 17Sale145.245,000726,19213,615Mar 18 08:49 PM
WALT DAVID RDirectorMar 15Option Exercise13.304,00053,200635,840Mar 16 09:16 PM
WALT DAVID RDirectorMar 15Sale149.994,000599,961631,840Mar 16 09:16 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMar 14Sale155.915,892918,61834,679Mar 15 07:42 PM
OSTADAN OMEADEVP Ops, Products, StrategyMar 09Sale150.32871130,92955,189Mar 11 11:43 AM
FLATLEY JAY TChief Executive OfficerMar 08Option Exercise36.3010,000363,000500,915Mar 09 06:45 PM
Dadswell CharlesSr VP & General CounselMar 08Sale155.648,2661,286,51758,241Mar 09 06:38 PM
FLATLEY JAY TChief Executive OfficerMar 08Sale154.4910,0001,544,864490,915Mar 09 06:45 PM
OSTADAN OMEADEVP Ops, Products, StrategyMar 08Sale156.094,516704,90256,060Mar 09 06:52 PM
Dadswell CharlesSr VP & General CounselMar 07Sale155.0011617,98066,507Mar 09 06:38 PM
Bouchard MichelChief Accounting OfficerMar 03Option Exercise0.008,250023,746Mar 07 08:14 PM
Dadswell CharlesSr VP & General CounselMar 03Option Exercise0.0033,750075,325Mar 07 07:56 PM
HENRY CHRISTIAN OEVP & Chief Commercial OfficerMar 03Option Exercise0.0024,000047,536Mar 07 07:58 PM
Naclerio NicholasSr VP, Corporate DevelopmentMar 03Option Exercise0.0020,063040,866Mar 07 08:00 PM
ORPIN TRISTANEVP Clinical GenomicsMar 03Option Exercise0.0024,0000125,797Mar 07 08:02 PM
Ronaghi MostafaSr VP & CTOMar 03Option Exercise0.0020,063062,763Mar 07 08:05 PM
deSouza Francis APresidentMar 03Option Exercise0.0049,2190118,880Mar 07 08:07 PM
FLATLEY JAY TChief Executive OfficerMar 03Option Exercise0.0083,8300514,614Mar 07 08:09 PM
Stapley MarcEVP & Chief Administrative OfcMar 03Option Exercise0.0024,000040,801Mar 07 08:11 PM
FLATLEY JAY TChief Executive OfficerFeb 23Option Exercise36.3010,000363,000440,784Feb 25 07:05 PM
FLATLEY JAY TChief Executive OfficerFeb 23Sale152.4910,0001,524,850430,784Feb 25 07:05 PM
BRADBURY DANIELDirectorFeb 17Option Exercise44.511,70075,66716,076Feb 19 11:27 AM
BRADBURY DANIELDirectorFeb 17Sale154.741,700263,05114,376Feb 19 11:27 AM
OSTADAN OMEADEVP Ops, Products, StrategyFeb 01Sale156.731,108173,65746,476Feb 03 06:58 PM
FLATLEY JAY TChief Executive OfficerJan 26Option Exercise36.3020,000726,000453,423Jan 28 06:09 PM
FLATLEY JAY TChief Executive OfficerJan 26Sale171.7020,0003,434,082433,423Jan 28 06:09 PM
BRADBURY DANIELDirectorJan 04Option Exercise44.511,70075,66716,076Jan 04 06:33 PM
BRADBURY DANIELDirectorJan 04Sale182.801,700310,75614,376Jan 04 06:33 PM
Dadswell CharlesSr VP & General CounselDec 28Sale188.6316831,69041,830Dec 30 02:36 PM
FLATLEY JAY TChief Executive OfficerDec 22Option Exercise31.3025,000782,550458,423Dec 24 10:54 AM
FLATLEY JAY TChief Executive OfficerDec 22Sale185.3825,0004,634,560433,423Dec 24 10:54 AM
WHITFIELD ROY ADirectorDec 14Option Exercise36.293,750136,08817,398Dec 15 05:40 PM
WHITFIELD ROY ADirectorDec 14Sale175.073,750656,51313,648Dec 15 05:40 PM
OSTADAN OMEADEVP Ops, Products, StrategyDec 11Sale179.9026046,77448,293Dec 14 05:46 PM
Bianchi Paul LSr. VP, Human ResourcesDec 11Sale179.9019735,44059,827Dec 14 05:48 PM
BRADBURY DANIELDirectorDec 10Option Exercise44.511,70075,66716,076Dec 11 06:47 PM
BRADBURY DANIELDirectorDec 10Sale182.371,700310,03714,376Dec 11 06:47 PM
Dadswell CharlesSr VP & General CounselNov 27Sale180.7216930,54240,553Nov 30 05:38 PM
EPSTEIN ROBERT SDirectorNov 27Sale185.561,000185,5606,935Nov 30 05:41 PM
FLATLEY JAY TChief Executive OfficerNov 25Option Exercise27.975,000139,850428,793Nov 27 09:52 AM
FLATLEY JAY TChief Executive OfficerNov 25Sale180.005,000900,000423,793Nov 27 09:52 AM
FLATLEY JAY TChief Executive OfficerNov 24Option Exercise27.9720,000559,400443,793Nov 25 01:56 PM
FLATLEY JAY TChief Executive OfficerNov 24Sale173.2720,0003,465,342423,793Nov 25 01:56 PM
FLATLEY JAY TChief Executive OfficerNov 16Option Exercise27.9710,000279,700433,793Nov 17 08:29 PM
FLATLEY JAY TChief Executive OfficerNov 16Sale170.0010,0001,700,000423,793Nov 17 08:29 PM
Klausner RichardSr VP, Chief Medical OfficerNov 13Sale163.52730119,37023,100Nov 16 05:16 PM
BRADBURY DANIELDirectorNov 10Option Exercise44.511,70075,66716,076Nov 12 07:42 PM
BRADBURY DANIELDirectorNov 10Sale154.031,700261,84614,376Nov 12 07:42 PM
WALT DAVID RDirectorNov 10Sale154.032,000308,06436,960Nov 12 09:22 PM
Dadswell CharlesSr VP & General CounselNov 03Sale150.0015823,70040,847Nov 04 05:44 PM
FLATLEY JAY TChief Executive OfficerOct 15Option Exercise27.9710,000279,700434,996Oct 16 09:10 PM
FLATLEY JAY TChief Executive OfficerOct 15Sale150.0010,0001,500,000424,996Oct 16 09:10 PM
BRADBURY DANIELDirectorOct 07Option Exercise44.511,70075,66716,076Oct 07 07:46 PM
BRADBURY DANIELDirectorOct 07Sale145.811,700247,87814,376Oct 07 07:46 PM
WALT DAVID RDirectorSep 29Sale171.652,000343,29438,960Oct 01 05:47 PM
Dadswell CharlesSr VP & General CounselSep 28Sale173.2015727,19241,005Sep 28 07:11 PM
Klausner RichardSr VP, Chief Medical OfficerSep 28Sale173.2042373,26424,016Sep 29 04:26 PM
FLATLEY JAY TChief Executive OfficerSep 22Option Exercise27.9725,000699,250449,996Sep 23 12:42 PM
FLATLEY JAY TChief Executive OfficerSep 22Sale192.7925,0004,819,681424,996Sep 23 12:42 PM
WALT DAVID RDirectorSep 15Sale206.452,000412,89440,960Sep 17 07:39 PM
Bianchi Paul LSr. VP, Human ResourcesSep 09Sale199.321,245248,15358,519Sep 10 06:02 PM
FLATLEY JAY TChief Executive OfficerSep 08Option Exercise27.9725,000699,250449,996Sep 08 05:57 PM
EASTHAM KARINDirectorSep 08Option Exercise44.514,300191,39314,719Sep 08 06:02 PM
FLATLEY JAY TChief Executive OfficerSep 08Sale194.8725,0004,871,849424,996Sep 08 05:57 PM
EASTHAM KARINDirectorSep 08Sale195.764,300841,76810,419Sep 08 06:02 PM
WHITFIELD ROY ADirectorSep 04Option Exercise36.294,500163,30518,148Sep 09 07:56 PM
WHITFIELD ROY ADirectorSep 04Sale192.634,500866,83513,648Sep 09 07:56 PM
WALT DAVID RDirectorSep 01Sale195.082,000390,15142,960Sep 01 05:44 PM
FLATLEY JAY TChief Executive OfficerAug 27Option Exercise27.9725,000699,250449,996Aug 31 06:01 PM
Dadswell CharlesSr VP & General CounselAug 27Sale198.8116332,40641,162Aug 31 05:34 PM
FLATLEY JAY TChief Executive OfficerAug 27Sale200.1625,0005,004,125424,996Aug 31 06:01 PM
WALT DAVID RDirectorAug 18Sale206.892,000413,78544,960Aug 19 06:55 PM
BRADBURY DANIELDirectorAug 17Option Exercise75.661,700128,62216,076Aug 19 06:44 PM
BRADBURY DANIELDirectorAug 17Sale208.141,700353,84414,376Aug 19 06:44 PM
FLATLEY JAY TChief Executive OfficerAug 13Option Exercise27.9725,000699,250449,996Aug 13 06:51 PM
FLATLEY JAY TChief Executive OfficerAug 13Sale207.8525,0005,196,268424,996Aug 13 06:51 PM
Bouchard MichelChief Accounting OfficerAug 12Sale205.001,408288,64015,000Aug 13 06:03 PM
WALT DAVID RDirectorAug 11Sale208.695,4971,147,187648,840Aug 12 07:05 PM
EPSTEIN ROBERT SDirectorAug 10Option Exercise51.172,000102,3409,935Aug 12 06:46 PM
EPSTEIN ROBERT SDirectorAug 10Sale212.092,000424,1807,935Aug 12 06:46 PM